Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

  • There is currently no data for AGL

IN BRIEF: Angle highlights supportive data for DNA analysis tool

Mon, 22nd Jan 2024 18:03

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.

Current stock price: 17.85 pence, down 8.5% in London on Monday

12-month change: down 42%

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Related News

IN BRIEF: Angle names Peter Collins as interim CEO
16 Oct 2025

IN BRIEF: Angle names Peter Collins as interim CEO

(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...

Angle touts planned name and strategy change, Groen turns executive
8 Oct 2025

Angle touts planned name and strategy change, Groen turns executive

(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...

IN BRIEF: Angle CEO and finance lead step down after shareholder talks
12 Sep 2025

IN BRIEF: Angle CEO and finance lead step down after shareholder talks

Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...

Angle News

Angle Appoints Cancer Diagnostic Firm Chief As Non-Executive Director
1 Nov 2018

Angle Appoints Cancer Diagnostic Firm Chief As Non-Executive Director

LONDON (Alliance News) - Biopsy company Angle PLC said Thursday it has appointed the President of Euronext-listed cancer diagnostics firm MDxHealth to...

Angle Pilot Study Shows Promise Of Parsortix In Prenatal Testing
29 Oct 2018

Angle Pilot Study Shows Promise Of Parsortix In Prenatal Testing

LONDON (Alliance News) - Liquid biopsy company Angle PLC on Monday said it has received positive results from a study examining the use of its Parsort...

Angle sees 'highly encouraging' results from prenatal testing
29 Oct 2018

Angle sees 'highly encouraging' results from prenatal testing

(Sharecast News) - Medical diagnostics outfit Angle is talking to "several interested parties" to commercialise its testing device after a "highly enc...

Angle Nearing Completion Of Patient Enrolment Breast Cancer Study
25 Oct 2018

Angle Nearing Completion Of Patient Enrolment Breast Cancer Study

LONDON (Alliance News) - Liquid biopsy firm Angle PLC said it is making good progress on recruiting patients for its ANG-002 clinical study.The study ...

Angle makes 'good progress' with ANG-002 patient enrolment
25 Oct 2018

Angle makes 'good progress' with ANG-002 patient enrolment

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that patient enrolment for its ANG-002 FDA clinical study for metastatic breast c...

UK Shareholder Meetings Calendar - Next 7 Days
23 Oct 2018

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 24 OctoberIndigovisionBeeks FinancialReddePhoto-Me 25 & Smart 26 29 30

Angle's Parsortix System Able To Identify Tumour Cells In Glioblastoma
28 Aug 2018

Angle's Parsortix System Able To Identify Tumour Cells In Glioblastoma

LONDON (Alliance News) - Angle PLC on Tuesday said researchers at the Cancer Metastasis Laboratory, located at the University of Basel, have provided ...